Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
33%
Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

not_yet_recruiting133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_2

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

NCT07658924
unknownphase_3

Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis

NCT05326672
unknownnot_applicable

Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis

NCT05326659

Clinical Trials (3)

Showing 3 of 3 trials
NCT07658924Phase 2

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

Not Yet Recruiting
NCT05326672Phase 3

Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Unknown
NCT05326659Not Applicable

Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3